Transcatheter Embolization Market Growing as advanced embolic materials, rising procedure volumes, and expanding clinical applications drive steady global growth. Many hospitals, physicians, and device makers look for safer, more precise ways to manage a wide range of vascular and tumor-related conditions.
New embolic materials, growing clinical experience, and broader therapeutic applications are shaping how this market develops worldwide. Understanding these shifts may help teams spot where demand is rising and how different device categories are evolving.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ What is Transcatheter Embolization?
➜ What Is Driving Growth in the Transcatheter Embolization Market?
➜ How Are Advanced Embolic Materials Shaping the Transcatheter Embolization Market?
➜ What Competitive Trends Are Influencing the Transcatheter Embolization Market?
➜ How Are Procedure Volumes Changing in the Transcatheter Embolization Market?
➜ Why Are Detachable Coils Growing Faster in the Transcatheter Embolization Market?
➜ How Do Specialized Applications Impact Transcatheter Embolization Market Costs?
➜ How Is Physician Training Supporting Growth in the Transcatheter Embolization Market?
➜ Transcatheter Embolization Market Outlook
Key Takeaways
- Market research today focuses on precise procedure counts, competitor shares, and technology adoption trends.
- Claims data, regulatory databases, and surgeon-level interviews are becoming key sources of reliable evidence.
- Companies use market research for strategy, R&D, forecasting, and competitive planning.
- Investors rely on medical market research to understand risk and growth signals early.
- Choosing the right research partner reduces delays and costly product misalignment.
What is Transcatheter Embolization?
Transcatheter embolization is a minimally invasive procedure that blocks blood flow to a specific area of the body. Physicians thread a small catheter through the blood vessels and release coils, particles, or liquid agents to target the site.
This approach is used in many areas of care, including tumor treatment, uterine fibroid management, gastrointestinal bleeding, and arteriovenous malformations.
Its popularity continues to grow because it often offers shorter recovery times, fewer complications, and more precise control compared to open surgery.
As hospitals expand their interventional radiology programs, embolization is becoming an important option for patients who need targeted, image-guided therapy.
What Is Driving Growth in the Transcatheter Embolization Market in 2025?
Some analysts note that growth niches in the U.S. peripheral vascular market, driven by rising rates of peripheral artery disease (PAD) and endovascular interventions, may indirectly support embolization demand. As clinicians become more experienced with catheter-based techniques to treat peripheral vascular conditions, clinical comfort with other transcatheter procedures may expand over time.
Interventional radiology, which includes embolization, is increasingly valued for offering targeted treatment with reduced trauma and shorter hospital stays compared to traditional surgery – a trend noted in educational nursing literature.
Growth in the transcatheter embolization market is tied to several interconnected trends. Hospitals are performing more embolization procedures across oncology, vascular malformations, gastrointestinal bleeding, and other conditions. At the same time, embolic agents and delivery systems are becoming more advanced, which may encourage wider adoption.
Rising awareness of minimally invasive care also plays a role. Many physicians are turning to embolization as a way to treat disease while reducing recovery time. As these techniques improve, the data suggest that market growth may continue at a steady pace through the forecast period.
👉 Learn more in the Transcatheter Embolization Market Report
How Are Advanced Embolic Materials Shaping the Transcatheter Embolization Market?
A major trend in the transcatheter embolization market is the shift toward next-generation microspheres, liquid embolics, and drug-eluting technologies. These materials often offer greater precision, better controllability, and more predictable outcomes compared to traditional options.
Trends in the U.S. vascular access devices market, including growth in smaller-profile introducers, sheaths, and access technologies, may also influence embolization use by improving procedural ease and safety, particularly in peripheral and visceral vascular interventions.
Physicians are also adopting embolic products for an expanding set of uses. Beyond oncology, these materials are now used in vascular malformations, uterine fibroid procedures, and gastrointestinal bleeding. This wider range of clinical applications highlights how quickly the market is evolving and where future demand may rise.
What Competitive Trends Are Influencing the Transcatheter Embolization Market?
Competition is strong across coils, particles, and specialized embolic agents. Several notable developments include:
- Boston Scientific, after acquiring BTG, expanded its portfolio with Contour® PVA particles, TheraSpheres®, and DC-Beads®. The company held a leading position in the coil embolic market in 2025, supported by offerings such as VortX® pushable coils and Interlock-35™ detachable coils. As physician preference increasingly favors detachable designs, Boston Scientific’s share may see modest growth.
- Medtronic continues to compete with its Concerto™ detachable coil system and the Onyx® Liquid Embolic System. While Onyx® is approved for intracranial AVMs, it is frequently used off-label in peripheral cases and in treating endoleaks. Past legal settlements related to off-label promotion remain part of the company’s history, but the system remains a well-recognized product in the category.
- Sirtex Medical leads the niche radioactive particle segment with SIRSpheres®. Expanded reimbursement in regions such as France and the U.K., along with delivering over 100,000 patient doses by 2019, highlights the company’s strong positioning in high-value applications.
These competitive strategies show how companies may be differentiating themselves through technology depth, clinical performance, and reimbursement access.
How Are Procedure Volumes Changing in the Transcatheter Embolization Market?
The overall number of embolization procedures is expected to rise through the forecast period. Growth is largely linked to coil-based and particle-based procedures, which continue to expand across multiple therapeutic areas.
Device usage varies by anatomy and treatment goal. Data from 2025 show:
- Radioactive particles: ~1 vial per procedure
- Drug-eluting particles: ~1.2 vials per procedure
- Bland microspheres: ~3.2 vials per procedure on average
While open heart surgery remains essential for many complex cardiac conditions, interest is growing in minimally invasive transcatheter approaches for select structural and vascular procedures. This shift toward less invasive care, observed in technologies such as transcatheter valve replacement, reflects broader clinical interest in catheter-based treatments that can shorten recovery time and reduce hospital stays.
These differences reflect how each particle type functions, whether to create ischemia, deliver a therapeutic dose, or combine both effects. As hospitals treat a broader mix of cases, these usage patterns may influence purchasing behavior and inventory planning.
Why Are Detachable Coils Growing Faster in the Transcatheter Embolization Market?
Detachable coils carry a higher price than pushable coils because they can be repositioned or retracted before final deployment. This added control is valuable in complex vascular cases.
Their versatility is one reason why the detachable coil segment is expected to grow faster than traditional pushable coils.
As more organizations seek precision in vascular occlusion procedures, the data suggest that demand for detachable systems may continue to expand during the forecast period.
How Do Specialized Applications Impact Transcatheter Embolization Market Costs?
Some of the highest-value products in the transcatheter embolization market are linked to specialized treatments such as radioembolization or targeted drug delivery. For example, certain radiolabeled particles can exceed €10,000 per unit.
Because embolization can be used to block blood flow, shrink tumors, or deliver radiation or drugs directly to targeted tissue, costs vary widely. This range may influence budget planning for hospitals, especially as advanced therapies continue to gain attention in interventional oncology.
How Is Physician Training Supporting Growth in the Transcatheter Embolization Market?
Embolization requires highly trained physicians. As more clinicians gain expertise in handling coils, microspheres, and liquid embolics, the number of procedures performed is likely to increase.
This expanding pool of trained specialists may help sustain long-term market growth, since greater procedural capacity often aligns with higher overall adoption.
Transcatheter Embolization Market Outlook
The transcatheter embolization market in 2025 shows steady expansion driven by advanced materials, rising procedure volumes, and ongoing competition among leading device makers. As applications broaden and physicians gain more training, the data indicate that this market may continue its upward trajectory.
For a deeper look at forecasts, competitive share, and device-level segmentation, iData’s full market report provides detailed insights to support strategic planning.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
